Fig. 1From: The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 geneGivinostat increases maximal normalized strength (FNmax) in mdx mice in a dose-response manner. Givinostat treatment started on day 7. Data are expressed as the mean ± standard error (n = 9; wt: wild type)Back to article page